drugset / Trial / NCT02307630
PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study
Active not recruiting
7 enrolled
Memorial Sloan Kettering Cancer Center
Y-mAbs Therapeutics · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to find out how an antibody called Hu3F8 travels through the body and to tumors. Antibodies, like Hu3F8, are proteins that help attack tumors or fight infections. Antibodies can be made by your own body or in a laboratory. The target of an antibody is called an antigen; antibodies fit their antigen like a lock fits a key.
Timeline
- Start
- 2014-11
- Primary completion
- 2026-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 124I-Humanized 3F8 | Unknown | 3 unknown | Intravenous |